647
Participants
Start Date
October 31, 2025
Primary Completion Date
May 31, 2028
Study Completion Date
November 30, 2028
Tuberculosis window prophylaxis with weekly rifapentine and isoniazid for 12 weeks
Weekly isoniazid and rifapentine for 12 weeks (3HP regimen) will be provided to all participants.
Standard of care tuberculosis prophylaxis with weekly rifapentine and isoniazid for 12 weeks
Weekly isoniazid and rifapentine for 12 weeks (3HP regimen) will be provided only to participants with a positive IGRA result at baseline.
Hospital Dr. Carlos Cisterna, Calama
Hospital de Coquimbo, Coquimbo
Hospital San Juan de Dios de La Serena, La Serena
Hospital Claudio Vicuña, San Antonio
Hospital Dr. Gustavo Fricke, Viña del Mar
Hospital de Niños Roberto del Río, Independencia
Hospital Luis Calvo Mackenna, Providencia
Complejo Asistencial Dr. Sótero Del Río, Puente Alto
Hospital El Pino, San Bernardo
Hospital Clínico Félix Bulnes, Santiago
Hospital Clínico San Borja Arriarán, Santiago
Hospital San Juan de Dios de Santiago, Santiago
Hospital Alto Hospicio, Alto Hospicio
Pontificia Universidad Catolica de Chile
OTHER